Thermo Fisher Scientific Inc.

TMO ·Technology, Scientific & Technical Instruments, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $20.95B $18.26B $16.95B $16.89B $13.10B $12.51B $11.56B $10.79B
Life Sciences Solutions $5.73B $4.95B $4.41B $4.19B $1.42B $1.38B $1.31B $1.25B
Analytical Instruments $4.72B $3.31B $3.13B $3.18B $3.12B $2.91B $2.72B $2.48B
Specialty Diagnostics $3.49B $3.32B $3.11B $3.21B $2.98B $2.88B $2.65B $2.08B
Laboratory Products and Services $7.01B $6.68B $6.30B $6.31B $5.58B $5.34B $4.88B $4.98B
Cost of Revenue $8.98B $8.21B $7.58B $7.93B $6.31B $6.10B $5.73B $5.26B
Gross Profit $11.97B $10.05B $9.37B $8.96B $6.79B $6.41B $5.83B $5.53B
Gross Margin 57.2% 55.0% 55.3% 53.0% 51.8% 51.2% 50.4% 51.2%
Operating Expenses
Research & Development $887.0M $754.0M $692.0M $691.1M $395.5M $376.4M $340.2M $284.4M
SG&A Expense $5.50B $4.97B $4.61B $4.90B $3.45B $3.35B $3.11B $2.73B
Operating Income $2.96B $2.46B $2.34B $2.50B $1.61B $1.48B $1.25B $1.19B
Operating Margin 14.1% 13.5% 13.8% 14.8% 12.3% 11.8% 10.8% 11.0%
Interest Expense $592.0M $469.0M $415.0M $479.9M $262.1M $241.6M $175.3M $84.7M
Pretax Income $2.43B $2.02B $1.94B $2.09B $1.32B $1.27B $1.13B $1.09B
Income Tax Expense $201.0M $-1.0M $-44.0M $191.7M $40.4M $11.0M $109.4M $101.6M
Net Income $2.23B $2.02B $1.98B $1.89B $1.27B $1.18B $1.33B $1.04B
Net Margin 10.6% 11.1% 11.7% 11.2% 9.7% 9.4% 11.5% 9.6%
EPS (Basic) $5.64 $5.12 $4.96 $4.76 $3.53 $3.24 $3.49 $2.57
EPS (Diluted) $5.59 $5.09 $4.92 $4.71 $3.48 $3.21 $3.46 $2.53
Shares Outstanding (Basic) 395.0M 395.0M 399.0M 398.2M 360.3M 363.8M 380.8M 403.3M
Shares Outstanding (Diluted) 398.0M 397.0M 402.0M 402.3M 365.8M 366.6M 384.8M 409.4M
Dividends Per Share $0.60 $0.60 $0.60 $0.60 $0.60 $0.54 $0.00 $0.00
← Newer Page 2 of 3 Older →